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Abstract  
Background: Hepatitis C virus (HCV) infection is a significant cause of morbidity and mortality in 
end stage renal disease (ESRD) patients on hemodialysis (HD).  Routine HCV viremia screening is 
recommended in those patients but it is not applied. 
Aim: To evaluate the seroconversion rate in HD patients based on viremia detection compared to 
antibody (Ab), and to assess the role of isolation on the rate of seroconversion in those patients. 
Materials and Methods: One hundred ESRD patients from two HD units using same infection 
control criteria were enrolled in the study; only one unit was applying isolation for HCV patients. 
Patients were followed up for 12 month; HCV positivity was tested at the begining of the study and 
after 12 month of HD. HCV Ab and viremia were detected by third generation ELISA and PCR 
respectively.  
Results: The seroconversion rate was 0% based on HCV Ab detection by ELISA, compared with 
the 16 % seroconversion rate based on viremia detection by PCR. Notably, viremia seroconversion 
was seen only in the HD unit lacking the isolation system.  
Conclusion: HCV screening in HD units should be based on viremia detection; isolation in HD 
units prevents HCV spreading. 
  
 
 
 
Introduction 
Worldwide, 130–170 million persons are living 
with chronic hepatitis C virus (HCV) infection [1], 
which, if left untreated, can result in cirrhosis and liver 
cancer. Egypt has the largest burden of HCV infection 
in the world, with a 14% prevalence of chronic HCV 
infection among persons aged 15–59 years [2]. HCV 
transmission in Egypt is associated primarily with 
inadequate infection control during medical and dental 
care procedures [3, 4]. 
Hepatitis C virus (HCV) infection is a severe 
problem in maintenance hemodialysis patients whom 
are at particular high risk for blood-borne infections 
because of prolonged vascular access and potential 
for exposure to contaminated equipment [5] 
The prevalence of HCV infection among 
dialysis patients is generally much higher than healthy 
blood donors and general population. Studies held in 
dialysis centers from different countries revealed that 
prevalence ranges form 1-84.6% and there is a 
particular concern because HCV chronic infection 
causes significant morbidity and mortality among 
patients undergoing hemodialysis (HD) [6]. In Egypt 
the prevalence of HCV infection was variable ranging 
from 49% to 64% [7]. 
Risk factors for HCV infection in dialysis 
patients include number of blood transfusions, 
duration of HD, and mode of dialysis, prevalence of 
HCV infection in the dialysis unit, previous organ 
transplantation, intravenous drug use, male gender, 
older age, and nosocomial transmission of HCV in HD 
units [8-11]. 
The spread of HCV infection in HD units is 
mainly due to nosocomial transmission between 
patients [12, 13]. In order to control the diffusion of 
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HCV in hemodialysis units some authors 
recommended using a separate section to dialyze 
HCV+ patients [14], especially in hemodialysis units 
with a high HCV prevalence or in which there is no 
fulltime infection control personnel dedicated to the 
infected patients during the hemodialysis sessions, 
could have a greater risk of sero-conversion [15]. 
Prompt detection of de novo HCV among 
dialysis patients is required to limit nosocomial spread 
of HCV. Enzyme immunoassay (EIA) provided 
excellent accuracy, with 0–0.23% false-negative rates. 
Thus, EIA-3 is an effective screening tool for HCV 
infection in patients with ESRD [16]. But, similar to 
other viral infections, the window period in HCV 
infection is still a major problem. During the window 
period, specific antibodies are not detectable, but the 
virus is present in the blood. For this reason, anti-HCV 
tests are unable to identify the subjects in this early 
stage of infection. The stage prior to seroconversion 
may last up to 2 months in immunocompetent 
subjects and as long as 6–12 months in 
immunodeficient patients [17]. Consequently, 
implementation of high sensitivity techniques for 
screening of HCV viremia in HD units should be 
applied. 
The aim of this study was to evaluate the rate 
of seroconversion in anti HCV Ab negative and 
viremia negative patients after 12 month HD by PCR 
and to assess the role of isolation on the rate of 
seroconversion in those patients.  
 
Materials and Methods 
Study population 
The prospective study included 100 end stage 
Renal disease (ESRD) Egyptian patients who 
underwent regular HD, fifty of them (Group A) 
recruited from a University hospital HD unit and the 
other fifty patients (Group B) were selected from a 
private HD unit. These two HD units are using the 
same infection control guidelines.  Patient selection 
criteria was to be seronegative on three successive 
testing and to be confirmed in our lab as HCV RNA 
negative, those who proved HCV Ab negative but 
HCV RNA positive were excluded from the study. This 
study was approved by the local research ethics 
committee of National Research Center and a written 
informed consent was obtained from all participants in 
this study.  
 
Virological testing 
The detection of HCV antibodies (Ab) was 
determined every three month of the study by third 
generation ELISA (Dia Sorin, Torino, Italy) according 
to the manufacturer protocol. Serum RNA was 
extracted using Biozol reagent according to 
manufacturer protocol, HCV was detected using the 
conventional reverse transcription-polymerase chain 
reaction (RT- PCR) as described previously [18].  
 
Statistical analysis 
Statistical analysis was performed using 
version 16 of the SPSS computer program. Data of 
different variables were expressed as means ± SD. T-
test was used to compare means for continuous 
variables and for non-normally distributed continuous 
variables. Comparison between distributions of 
categorical variables was performed using Chi-square 
(χ²) test. In addition, variables were described as odds 
ratio (OR) with 95% confidence interval (95% CI) 
where appropriate. The data were considered 
significant if p values was < 0.05 and highly significant 
if p < 0.01. 
 
Results 
Demographic data, clinical and laboratory 
investigations of the study population 
The demographic data and clinical 
procedures for patients included in the current study 
were outlined as shown in Table 1; the laboratory 
investigations of the two groups of patients before and 
after HD are summarized in Table 2.  
Table 1: Demographic and clinical procedures for patient’s 
groups. 
Variable Group A Group B P value 
Age 53 ± 9.07 47 ± 13.51 0.015 
Gender M/F 33/17 29/21 0.679 
No of blood transfusion 
mean ± SD 
5.04 ± 3.67 1.4 ± 1.12 0.0001 
Dialysis duration / 
months 
mean ± SD 
79.78 ± 56.42 46.28 ± 38.68 0.001 
No of operations 
mean ± SD 
   
Shifting between dialysis 
units +ve/-ve 
31/19 21/29 0.045 
Antibilharzial treatment 
+ve/-ve 
12/38 0/50 0.0001 
DM +ve/-ve 6/44 7/43 0.766 
+ve/-ve: positive, negative; DM: Diabetes Mellitus. 
 
In brief, except gender all seroconversion risk 
factors were significantly higher in group A compared 
to group B. Notably, ALT level was significantly higher 
in group A before HD, and this difference was lost 
after HD due to elevation of its level in group B after 
HD. 
 
  Results of detection of HCV RNA after HD 
  After one year of HD, all patients were HCV 
Ab negative by ELISA. While HCV RNA was detected 
in 16% of group B patients, but none of group A 
patients had detectable HCV RNA Table 3. 
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Table 2: Laboratory investigations of patients before and after 
HD. 
Variable      
  Before HD 
GA          GB 
P 
value 
    After HD 
GA           GB 
P 
value 
ALT U/l 
mean ± 
SD 
22.2±6.77 15.6±5.55 0.0001 26.88±17.12 28.58±24.27 0.68 
AST U/l 
mean ± 
SD 
25.92±7.01 23.26±7.45 0.069 27.6±12.99 29.3±13.15 0.512 
BIL 
gm/dl 
mean ± 
SD 
0.649±0.428 0.834±.649 0.096 0.692±0.395 0.764±0.573 0.47 
ALB 
gm/dl 
mean ± 
SD 
3.47±0.481 3.646±0.467 0.076 3.506±0.539 3.604±0.6 0.393 
ALP U/I 
mean ± 
SD 
144.0±81.01 142.4±79.1 0.921 133.5±85.6 125.6±79 0.632 
PT/SEC 
mean ± 
SD 
15.4±5.32 11.66±1.319 0.0001 16.9±8.65 12.64±1.509 0.001 
Crm 
gm/dl 
mean ± 
SD 
8.722±3.09 8.612±2.07 0.209 8.732±2.6 9.198±2.594 0.372 
Hb 
gm/dl 
mean ± 
SD 
10.67±1.42 10.3±1.55 0.23 10.5±11.58 10.09±1.64 0.197 
Urea 
mg/dl 
mean ± 
SD 
163.8±61.00 180.4±51.34 0.143 155.62±62.9 161.66±63.3 0.633 
 
 
Discussion 
HCV chronic infection causes significant 
morbidity and mortality among patients undergoing 
hemodialysis (HD) [19]. Prompt diagnosis of HCV 
infection in patients on chronic hemodialysis is 
important not only to offer the appropriate treatment 
for those who require it, but also to decrease the rate 
of infection transmission in hemodialysis units. In 
patients with ESRD the prolonged window period and 
the risk of infection spread through hemodialysis 
devices are among other reasons to look for a simple, 
reliable diagnostic method for HCV infection even 
before anti-HCV Ab production, in this population of 
patients, as a critical step for the control of infection 
spread in hemodialysis units [20]. 
 
Table 3: HCV RNA Seroconversion results after HD. 
HCV RNA 
After HD 
GA                         GB 
      P value 
positive 0 42  
0.001 negative 50 8 
G:group. 
 
This study was conducted to assess the rate 
of seroconversion in HCV Ab and viremia negative HD 
patients using a sensitive PCR technique and to 
evaluate the role of isolation in HD units on the rate of 
seroconversion in this patient’s category. Results in 
this study revealed a statistically significant difference 
in the rate of seroconversion based on ELISA results 
(0%) compared to that based on PCR (16%). As they 
were HCV RNA negative at initiation of the study, this 
ensures either a false negative ELISA results or they 
may be at the window period and both explanations 
are satisfactory and are concordant with previous 
studies who showed that the rate of HCV ab negative 
viremia detected by PCR in hemodialysis patients was 
reported to be 0-12% globally and that a false neg-
ative rate of 17.9% has been detected for HCV Ab 
among Egyptian hemodialysis patients [21, 22]. 
Consequently, the rate of seroconversion calculated 
based on ELISA results only is underestimated and it 
is highly recommended to depend on PCR in HCV 
surveillance in Egyptian HD units, a conclusion that 
matches with previously described by Schneeberger 
et al, [23]. Nonetheless, this criterion is not yet 
applicable in most HD units in Egypt. 
As this study was designed to assess the role 
of isolation in HD units on seroconversion, the two HD 
units were chosen to be applying exactly the same 
infection control criteria, but isolation of HCV patients 
was applied in only one of them. Notably, the 
seroconversion was detected in patients of GB only 
but not in patients of GA, in other words 
seroconversion was not seen in patients from the HD 
unit applying the isolation strategy but was evident in 
patients from the HD unit not using the isolation 
policy.  
To ensure that the seroconversion was due to 
experiencing the isolation in the HD unit, we studied 
all other risk factors which may be responsible for it. 
As the infection control criteria were exactly the same, 
we compared seroconversion risk factors in the two 
groups including age, duration of HD, shifting between 
dialysis units, antibilharzial treatment, and presence of 
Diabetes Mellitus (DM). Strikingly, all of them were 
significantly higher in GA than GB patients; 
nonetheless GA patients maintained 0% 
seroconversion versus 16% seroconversion in GB, 
bringing a strong evidence of the isolation role in 
seroconversion in this study.    
The role of isolation in control of  HCV 
spreading in HD units is controversial, Although some 
studies found that nosocomial spread of HCV declined 
when HCV-infected patients were treated in dedicated 
HD units [24, 25], other investigators could control 
nosocomial spread of  HCV by strict application of 
hygienic precautions without isolation of HCV-infected 
subjects or machine segregation [26, 27]. Similarly in 
Egypt, results are controversial, while Shebeb et al., 
[28] showed that strict adherence to universal 
precautions was more effective than anti HCV 
seropositive patients isolation in limiting the spread of 
HCV infection among hemodialysis patients, two 
recent studies [29, 30] confirmed that strict isolation of 
HCV+ patients in combination with implementation of 
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universal prevention measures can limit the spread of 
HCV infection in HD patients. Notably all these studies 
evaluated seroconvertion by third generation ELISA 
only. In this study we emphasize the role of isolation 
of HCV positive patients on control of HCV infection 
spread in HD units in Egypt. 
In conclusion, surveillance of HCV in HD units 
should be done using PCR technique not only ELISA. 
Isolation of HCV positive patients in HD units protects 
from dissemination of HCV infection. 
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